LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3023% below fair value
$74.86−0.72 (-0.95%)
Close on Nov 19, 2026Market cap $1.71BP/E 26.3Yield 1.07%
LeMaitre Vascular free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
LeMaitre Vascular's free cash flow for the twelve months ending Jun 30, 2026 was $73.83M, up 41.1% year over year. For fiscal 2025 it was $74.47M, up 100.4% from the year before. Over ten years it grew 23.3% a year on average. The highest annual figure on record is $74.47M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.47M | +100.4% |
| FY2024 | Dec 31, 2024 | $37.16M | +26.0% |
| FY2023 | Dec 31, 2023 | $29.49M | +33.1% |
| FY2022 | Dec 31, 2022 | $22.15M | -26.7% |
| FY2021 | Dec 31, 2021 | $30.22M | -5.0% |
| FY2020 | Dec 31, 2020 | $31.82M | +205.4% |
| FY2019 | Dec 31, 2019 | $10.42M | -36.7% |
| FY2018 | Dec 31, 2018 | $16.45M | +0.0% |
| FY2017 | Dec 31, 2017 | $16.45M | +17.0% |
| FY2016 | Dec 31, 2016 | $14.06M | +53.4% |
| FY2015 | Dec 31, 2015 | $9.17M | +111.3% |
| FY2014 | Dec 31, 2014 | $4.34M | +63.4% |
| FY2013 | Dec 31, 2013 | $2.66M | -24.4% |
| FY2012 | Dec 31, 2012 | $3.51M | +205.7% |
| FY2011 | Dec 31, 2011 | $1.15M | -74.9% |
| FY2010 | Dec 31, 2010 | $4.58M | -5.8% |
| FY2009 | Dec 31, 2009 | $4.86M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.65M | -28.0% |
| Q1 FY2026 | Mar 31, 2026 | $12.31M | +60.8% |
| Q4 FY2025 | Dec 31, 2025 | $21.38M | +62.7% |
| Q3 FY2025 | Sep 30, 2025 | $26.48M | +110.6% |
| Q2 FY2025 | Jun 30, 2025 | $18.95M | +144.6% |
| Q1 FY2025 | Mar 31, 2025 | $7.66M | +106.9% |
| Q4 FY2024 | Dec 31, 2024 | $13.14M | +38.8% |
| Q3 FY2024 | Sep 30, 2024 | $12.58M | +16.8% |
| Q2 FY2024 | Jun 30, 2024 | $7.75M | -14.9% |
| Q1 FY2024 | Mar 31, 2024 | $3.70M | +2383.9% |
| Q4 FY2023 | Dec 31, 2023 | $9.47M | +236.1% |
| Q3 FY2023 | Sep 30, 2023 | $10.77M | +56.5% |
| Q2 FY2023 | Jun 30, 2023 | $9.10M | +10.0% |
| Q1 FY2023 | Mar 31, 2023 | $149.00K | -96.4% |
| Q4 FY2022 | Dec 31, 2022 | $2.82M | -36.7% |
| Q3 FY2022 | Sep 30, 2022 | $6.88M | -43.9% |
| Q2 FY2022 | Jun 30, 2022 | $8.28M | -2.6% |
| Q1 FY2022 | Mar 31, 2022 | $4.18M | -16.7% |
| Q4 FY2021 | Dec 31, 2021 | $4.45M | -65.6% |
| Q3 FY2021 | Sep 30, 2021 | $12.26M | -9.3% |
| Q2 FY2021 | Jun 30, 2021 | $8.49M | +68.7% |
| Q1 FY2021 | Mar 31, 2021 | $5.02M | +1438.3% |
| Q4 FY2020 | Dec 31, 2020 | $12.94M | +208.5% |
| Q3 FY2020 | Sep 30, 2020 | $13.52M | +259.5% |
| Q2 FY2020 | Jun 30, 2020 | $5.04M | +44.5% |
| Q1 FY2020 | Mar 31, 2020 | $326.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $4.19M | -20.6% |
| Q3 FY2019 | Sep 30, 2019 | $3.76M | -0.4% |
| Q2 FY2019 | Jun 30, 2019 | $3.49M | -14.4% |
| Q1 FY2019 | Mar 31, 2019 | -$1.02M | -130.7% |
| Q4 FY2018 | Dec 31, 2018 | $5.28M | +2.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.77M | -35.6% |
| Q2 FY2018 | Jun 30, 2018 | $4.07M | -12.8% |
| Q1 FY2018 | Mar 31, 2018 | $3.32M | +323.4% |
| Q4 FY2017 | Dec 31, 2017 | $5.13M | +61.3% |
| Q3 FY2017 | Sep 30, 2017 | $5.86M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.67M | – |
| Q1 FY2017 | Mar 31, 2017 | $785.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $3.18M | – |
See a number that looks wrong?